Inhibiting lysosomal aldolase: a magic bullet for AMPK activation in treating metabolic disease?

References

[1] Steinberg GR , Carling D . Nat Rev Drug Discov 2019; 18: 527- 51.

[2] Zhang CS , Li M , Wang Y et al. Nat Metab 2022; 4: 1369- 401.

[3] Zhang CS , Hawley SA , Zong Y et al. Nature 2017; 548: 112- 6.

[4] Zhang YL , Guo H , Zhang CS et al. Cell Metab 2013; 18: 546- 55.

[5] Li M , Zhang CS , Feng JW et al. Cell Metab 2019; 30: 508- 24.

[6] Zong Y , Zhang CS , Li M et al. Cell Res 2019; 29: 460- 73.

[7] Gluais-Dagorn P , Foretz M , Steinberg GR et al. Hepatol Commun 2022; 6: 101- 19.

[8] Myers RW , Guan HP , Ehrhart J et al. Science 2017; 357: 507- 11.

[9] Pollard AE , Martins L , Muckett PJ et al. Nat Metab 2019; 1: 340- 9.

[10] Apfeld J , O’Connor G , McDonagh T et al. Genes Dev 2004; 18: 3004- 9.

RIGHTS & PERMISSIONS

The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.